<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The Effects of Long-Term, Low-Level Exposure to Monocyclic Aromatic Hydrocarbons on Worker&apos;s Insulin Resistance</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2011-10-06">October 6, 2011</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yong</forename><surname>Lim Won</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Occupational Safety and Health Research Institute</orgName>
								<orgName type="institution" key="instit2">Korea Occupational Safety and Health Agency</orgName>
								<address>
									<settlement>Incheon</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yong</forename><surname>Ko</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Division of Biotechnology</orgName>
								<orgName type="department" key="dep2">College of Life Science and Biotechnology</orgName>
								<orgName type="institution">Korea University</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyung-Hwa</forename><surname>Heo</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Occupational Safety and Health Research Institute</orgName>
								<orgName type="institution" key="instit2">Korea Occupational Safety and Health Agency</orgName>
								<address>
									<settlement>Incheon</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyung</forename><forename type="middle">Sun</forename><surname>Ko</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Occupational Safety and Health Research Institute</orgName>
								<orgName type="institution" key="instit2">Korea Occupational Safety and Health Agency</orgName>
								<address>
									<settlement>Incheon</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mi-Young</forename><surname>Lee</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Occupational Safety and Health Research Institute</orgName>
								<orgName type="institution" key="instit2">Korea Occupational Safety and Health Agency</orgName>
								<address>
									<settlement>Incheon</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ki-Woong</forename><surname>Kim</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Occupational Safety and Health Research Institute</orgName>
								<orgName type="institution" key="instit2">Korea Occupational Safety and Health Agency</orgName>
								<address>
									<settlement>Incheon</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="laboratory">Occupational Safety and Health Research Institute Korea Occupational Safety and Health Agency</orgName>
								<address>
									<addrLine>104-8, Munji-dong, Yuseong-gu</addrLine>
									<postCode>305-380</postCode>
									<settlement>Daejeon</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The Effects of Long-Term, Low-Level Exposure to Monocyclic Aromatic Hydrocarbons on Worker&apos;s Insulin Resistance</title>
					</analytic>
					<monogr>
						<idno type="ISSN">p : 2093-7911</idno>
						<imprint>
							<date type="published" when="2011-10-06">October 6, 2011</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.5491/SHAW.2011.2.4.365</idno>
					<note type="submission">Received: April 18, 2011, Revised: July 25, 2011 Accepted: July 29, 2011,</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:16+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Aromatic hydrocarbons</term>
					<term>Insulin resistance</term>
					<term>Cytokines</term>
					<term>Oxidative stress [2</term>
					<term>3]</term>
					<term>hematopoietic organs [4]</term>
					<term>nervous system [5]</term>
					<term>immunoendocrinological system [6]</term>
					<term>kidney</term>
					<term>cardiovascular system</term>
					<term>skin</term>
					<term>mucosa</term>
					<term>and reproductive organs</term>
					<term>and have been reported to decrease or damage the body homeostasis maintenance</term>
				</keywords>
			</textClass>
			<abstract>
				<p>This study was designed to investigate whether long-term, low-level exposure to monocyclic aromatic hydrocarbons (MAHs) induced insulin resistance. Methods: The subjects were 110 male workers who were occupationally exposed to styrene, toluene, and xylene. One hundred and ten age-matched male workers who had never been occupationally exposed to organic solvents were selected as a control group. Cytokines, which have played a key role in the pathogenesis of insulin resistance, and oxidative stress indices were measured. Assessment of exposure to MAHs was performed by measuring their ambient levels and their urinary metabolites in exposed workers, and the resulting parameters between the exposed group and non-exposed control groups were compared. Results: There was no significant difference in general characteristics and anthropometric parameters between the two groups; however, total cholesterol, fasting glucose, fasting insulin, and homeostasis model assessment of insulin resistance levels were significantly higher in the exposed group. Phenylglyoxylic acid levels showed significant association with tumor necrosis factor-α, total oxidative status, and oxidative stress index via multiple linear regression analysis. Further, there was a negative correlation between methylhippuric acid levels and total anti-oxidative capacity, and there was a significant relationship between MAHs exposure and fasting glucose levels, as found by multiple logistic regression analysis (odds ratio = 3.95, 95% confidence interval = 1.074-14.530). Conclusion: This study indicated that MAHs increase fasting glucose level and insulin resistance. Furthermore, these results suggested that absorbing the organic solvent itself and active metabolic intermediates can increase oxidative stress and cytokine levels, resulting in the changes in glucose metabolism and the induction of insulin resistance.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Organic solvents are widely used at home as well as in work-places, and their health hazards have been known for a long time. Diverse hazardous chemicals, including organic solvents that humans are occupationally or non-occupationally exposed to, have their own physicochemical characteristics with various absorption routes and target organs. They have been demonstrated to cause toxicity in various organs <ref type="bibr" target="#b0">[1]</ref> including the liver www.e-shaw.org function <ref type="bibr" target="#b6">[7]</ref>.</p><p>Some studies have reported that exposure to organic solvents may be related to insulin resistance (IR) or associated metabolic syndrome (MetS). Kaukiainen et al. <ref type="bibr" target="#b7">[8]</ref> reported that workers exposed to organic solvent mixtures had higher fasting glucose levels, and Hong et al. <ref type="bibr" target="#b8">[9]</ref> mentioned that environmental contaminants including organic solvents may result in IR. Although the relationship between organic solvent exposure and IR has not been directly described, it has been reported that exposure to organic solvents increased cytokines including tumor necrosis factor-alpha (TNF-α) which are involved in inflammatory responses <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b9">10]</ref> and increased oxidative stress while reducing the activities of antioxidant enzymes <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>. It has also been reported that increased cytokines such as TNF-α, interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) play a critical role in the development of IR as well as being involved in immunological reactions and signal transductions <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>; and that increased reactive oxygen species (ROS) are involved in blood glucose elevation and development of IR through activating c-Jun NH 2 -terminal kinase (JNK) and Iκβ kinase B (IKKβ), which are stress kinases, leading to accelerated phosphorylation of insulin receptor substrate-1 (IRS-1) serine <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref>. However, studies on the relationship between exposure to low-level monocyclic aromatic hydrocarbons (MAHs) and IR and the pathogenesis of IR have been exceedingly insufficient in both Korea and other countries and thus, such studies are increasingly needed.</p><p>In this study, IL-1β, IL-6, and TNF-α, which are cytokines playing key roles in the pathogenesis of IR, and oxidative stress indices were measured in the subjects. Exposure to styrene, toluene, and xylene, which were representative MAHs, was assessed through measuring ambient levels and urinary metabolites in exposed workers. Finally, these parameters were compared between the exposed group and non-exposed control group to identify the effects of chronic exposure to low-level MAHs and IR in Korean workers.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head><p>This paper was a cross-sectional study aimed at inspecting the effect of low-level organic solvent exposure on insulin resistance. The subjects in the exposed group were workers who had been exposed to MAHs in paint manufacturing factories. Female subjects were excluded from this study as the number of female workers was not large enough to use in statistical calculations. The subjects in the control group were randomly selected among workers with a similar range in age as the subjects in the exposed group, in order to control the effects of aging. The level of organic solvent in the air and urinary metabolites in urine were set as exposure variables, and cytokines and oxidative stress levels were compared between the exposed and control groups. This study was reviewed and approved by the Institutional Review Board of the Occupational Safety and Health Research Institute, and informed consent was obtained from all the workers who volunteered to participate in the study.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study subjects</head><p>One hundred and ten male workers (mean age of 38.9) who were occupationally exposed to mixed organic solvents including styrene, toluene, and xylene in three paint manufacturing factories were selected as test subjects in the exposed group. The control group was composed of 110 age-matched (mean age of 38.6) male manufacturing workers and office workers at the same factories who had never been occupationally exposed to organic solvents. Workers with clinically diagnosed diabetes, those taking medication for a medical condition, and those with acute infections and/or diseases that may have suppressed their immune systems were excluded from the study.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Questionnaire survey</head><p>Self-administered questionnaires were distributed and in-person interviews were conducted to obtain information on the subjects' general characteristics including age, smoking, drinking, physical activity, job characteristics including daily working hours and working duration, and eating habits.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measuring ambient organic solvent levels and urinary metabolites</head><p>Ambient monitoring and biological monitoring was carried out for all the subjects. Ambient organic solvent levels were analyzed according to 'Method 1501 Aromatic Hydrocarbons' in National Institute of Occupational Safety and Health <ref type="bibr" target="#b16">[17]</ref>. Organic solvents in the air at the workplace were sampled using low-flow active samplers (Low Flow Sampler 113 D, Gilian, USA) and analyzed using gas chromatography (CP-3800 GC/ FID, Varian Ltd., USA). The urine used to measure the levels of urinary metabolites was obtained at around 18:00-19:00 after most workers had completed work. Urinary excretion of hippuric acid (HA) and methyl hippuric acid (mHA), which are metabolites of toluene and xylene, respectively, were analyzed using gas chromatography (CP-3800 GC/FID, Varian Ltd., USA), and the results were adjusted to urinary creatinine <ref type="bibr" target="#b17">[18]</ref>. Phenylglyoxylic acid (PGA) and mandelic acid (MA), metabolites of styrene, were analyzed using gas chromatography according to the method by Ogata and Taguchi <ref type="bibr" target="#b18">[19]</ref>, and</p><p>www.e-shaw.org the results were adjusted to urinary creatinine.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Blood collection and analysis</head><p>Venous blood was collected between 07:00 and 09:00 after the subjects had fasted for more than 10-hours, and centrifuged for 15 minutes at 2,500 rpm within 30 minutes after sampling to separate plasma and serum. Separated plasma and serum were divided into 100 μL vials and frozen, and transported to the laboratory for analysis where biochemical tests were performed using a biochemistry analyzer (COBAS Integra 400, Roche Diagnostics Ltd., Switzerland). Fasting insulin levels were analyzed using a luminescence immunoassay system (ACCESS, Sanofi Diagnostics Pasteur, Inc., Minnesota, USA). IL-1β, IL-6 and TNF-α were analyzed using a sandwich ELISA kit (R&amp;D systems, Minnesota, USA) by the method suggested by the manufacturer. All results are presented as mean values of duplicate measurements.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of oxidative stress</head><p>Total oxidative status (TOS) and total anti-oxidative capacity (TAC) were measured using a colorimetric test kit (Immunodiagnostik AG, Bensheim, Germany). For TOS, total lipid peroxides, which are directly correlated with oxygen radicals, were measured in the plasma and adjusted to reference material to calculate the concentration as a H 2 O 2 -equivalent (μmol/L). For TAC, H 2 O 2 remaining in the plasma after reaction with antioxidants for a specific time was measured to identify the reactivity of antioxidants (presented as H 2 O 2 -equivalent [μmol/L]). The oxidative stress index (OSI) which was the TOS-to-TAC ratio was calculated using the equation, OSI (arbitrary unit) = TOS</p><formula xml:id="formula_0">(μmol H 2 O 2 equivalent/L) / TAC (μmol H 2 O 2 equivalent/L).</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of insulin resistance</head><p>Insulin resistance was evaluated using a homeostasis model assessment of insulin resistance (HOMA-IR). The HOMA-IR was calculated using the equation, [HOMA-IR = fasting insulin (μU/mL) × fasting glucose (mg/dL) / 405].</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data analysis</head><p>The data was analyzed using SPSS software version 12.0.1 (SPSS Inc., Chicago, IL, USA). T-tests were performed to compare the exposed and control groups, and multiple linear regression analysis and multiple logistic regression analysis was used to analyze the relationship between parameters. In the multiple logistic regression analysis, subjects with results in the upper 25% of HOMA-IR were considered part of the group having insulin resistance, and the lower 75% was considered part of normal group. Subjects with fasting plasma glucose lev-els greater than or equal to 100 mg/dL were considered part of the high-glucose group and those with lower levels were considered part of the normal group <ref type="bibr" target="#b19">[20]</ref>. All results were presented as mean ± standard deviation, and p-values less than 0.05 were considered significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Characteristics of the study subjects</head><p>The mean age of workers was 38.6 ± 8.5 and 38.9 ± 8.3 years in the control and exposed group, respectively. There were no significant differences in age, smoking and drinking rate, eating habits, and exercise habits between the two groups. TV viewing hours (1.4 ± 1.0 vs. 1.7 ± 0.9 hours per day) and department working duration (44.2 ± 56.9 vs. 114.8 ± 90.6 months) were significantly longer in the exposed group (p &lt; 0.05). The subjects in the exposed group worked on average, 9.1 ± 1.4 hours, during which they were exposed to organic solvents while subjects in the control group worked for longer hours at an average of 9.9 ± 1.6 hours (p &lt; 0.001). Additionally, there was no significant difference with respect to any anthropometric parameters between the control and exposed groups ( <ref type="table" target="#tab_0">Table 1)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Level of exposure to MAHs and its correlation with metabolites in the exposed group</head><p>Workers in the exposed group were exposed to average styrene levels of 0.10 ppm (range, 0.00-5.90) with mean levels of urinary PGA, a metabolite of styrene, of 0.02 g/g creatinine (range, 0.01-0.04). The correlation coefficient (r) between ambient styrene and urinary PGA level was 0.625 (p &lt; 0.05). Workers in the exposed group were exposed to average toluene levels of 0.14 ppm (range, 0.00-2.02) while HA, a urinary metabolite of toluene, was 0.30 g/g creatinine (range, 0.01-1.34). There was no significant correlation between ambient toluene and urinary HA levels. Workers in the exposed group were exposed to average xylene levels of 8.83 ppm (range, 0.00-32.65) while mHA, a urinary metabolite of xylene, was 0.09 g/g creatinine (range, 0.00-0.48). The correlation coefficient between ambient xylene and urinary mHA level was 0.316 (p &lt; 0.01). Ambient exposure levels of styrene, toluene, and xylene and concentrations of urinary excretion of their metabolites MA, PGA, HA, and mHA were all below the threshold limit value-time weighted average (TLV-TWA) and biological exposure index (BEI) of Korea, respectively <ref type="table" target="#tab_1">(Table 2)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Serum clinical parameters of the study subjects</head><p>Total cholesterol, fasting glucose, fasting insulin, and HOMA-IR levels were statistically significantly higher in the exposed www.e-shaw.org group (p &lt; 0.05), while HDL-cholesterol, LDL-cholesterol, triglyceride were not significantly different between groups. Further, TNF-α levels in the exposed group were significantly higher compared to levels in the control group (4.785 ± 1.975 pg/mL vs. 2.380 ± 1.635 pg/mL, p &lt; 0.001). IL-1β and IL-6 levels were higher in the exposed group, although the difference compared to those in the control group was not statistically significant. TOS, TAC and OSI were measured to examine the changes in oxidative stress by exposure to MAHs. TAC, which indicates anti-oxidative capacity, was significantly lower in the exposed group compared to levels in control group, while TOS and OSI were not statistically different between groups <ref type="table" target="#tab_2">(Table  3)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Relationship between MAHs metabolites and cytokines or oxidative stress indices</head><p>The results from the multiple linear regression analysis for the 110 exposed workers have been provided in <ref type="table" target="#tab_3">Table 4</ref>. Only the test items that had statistical significance have been listed. TNF-α was significantly affected by PGA (p &lt; 0.05), but other cytokines such as IL-6 and IL-1α were not significantly affected by independent variables (such as MA, PGA, HA and mHA). TOS (p &lt; 0.01) and OSI (p &lt; 0.01) were significantly affected by PGA positively, and TAC was negatively affected by mHA (p &lt; 0.05). www.e-shaw.org</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Relationship between exposure to MAHs and insulin resistance</head><p>After adjusting for the workers' age, smoking habits, drinking habits, waist and hip circumference, weight, and regular exercise habits, a multiple logistic regression analysis was performed (with exposure levels of MAHs as the independent variable, and fasting glucose and HOMA-IR levels as the dependent variable) in order to identify the relationship between exposure to MAHs and IR. The odds ratio (OR) between exposure levels of MAHs and fasting glucose was 3.951 (95% cofidence interval [CI] = 1.074-14.530, p = 0.039), indicating a significant relationship. The OR between exposure levels of MAHs and HOMA-IR was 1.713 (95% CI = 0.846-3.469, p = 0.135), which did not indicate a significant relationship <ref type="table">(Table  5</ref>). Also, after adjusting for age, increase in working duration to MAHs was related to increased blood glucose levels <ref type="figure">(Fig. 1)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>There have been many reports on the correlation between IR and lifestyle, but there are only a few studies regarding exposure to hazardous chemicals, despite the fact that many have suggested the relationship between exposure to organic solvents and IR. Therefore, we carried out this study to analyze the characteristics of working environments in manufacturing factories in Korea and analyzed their relationship with IR to   www.e-shaw.org compare the results with those from other countries and clearly identify the relationship. We studied styrene, toluene, and xylene, which are MAHs widely used in industries in paint, plastic and rubber manufacturing as thinner, and attempted to understand the effect of exposure to these chemicals on the development of IR with a specific focus on cytokines and oxidative stress. With regard to lifestyle, Pardee et al. <ref type="bibr" target="#b20">[21]</ref> reported that television viewing time was associated with hypertension and obesity, and that TV viewing time was reported to be positively correlated with BMI <ref type="bibr" target="#b21">[22]</ref>. Mummery et al. <ref type="bibr" target="#b22">[23]</ref> also reported that time spent sitting was positively correlated with BMI. In addition, De León et al. <ref type="bibr" target="#b24">[24]</ref> reported that there were direct associations between a sedentary lifestyle and triglyceride, IR, and MetS. Thus, these results suggest that induction of hypertension, obesity, IR, and MetS is associated with sedentary behaviors. However, in this study, a comparison of anthropometric results between the control and exposed groups showed no statistically significant difference. This result may be due to the lack of a significant difference in general characteristics that may have affected the anthropometric results between the groups. Therefore, we can induce that the effects of lifestyle and so on are ignorable in the various results of the analysis and in the the interpretation of the analysis in these two groups. Mokuda et al. <ref type="bibr" target="#b25">[25]</ref> reported that liver damage induced by carbon tetrachloride increased glucose and insulin levels in blood, and Kaukiainen et al. <ref type="bibr" target="#b7">[8]</ref> reported that fasting blood glucose levels were higher in those exposed to mixed organic solvents than in the control group who were not exposed to hazardous chemicals: organic solvent exposure was positively correlated with glucose, cholesterol and triglyceride though these were within reference ranges. In the present study, total cholesterol, fasting glucose, fasting insulin, and HOMA-IR were significantly higher in the exposed group. This result was comparable to other reports, and thought to be the effect of exposure to MAHs.</p><p>Styrene exposure has been reported to change the physiological levels of serotonin and TNF-α which are neurotransmitters <ref type="bibr" target="#b26">[26]</ref>, and TNF-α inhibits signaling by insulin through inhibiting IRS-1 function by serine phosphorylation <ref type="bibr" target="#b27">[27]</ref>. TNF-α is known to have a biological action opposite to adiponectin, even though its three-dimensional structure is very similar to that of adiponectin. These two are known to inhibit the production and action of each other <ref type="bibr" target="#b28">[28]</ref>. TNF-α also elevates blood fatty acids by promoting lipolysis in adipocytes, which may cause a decrease in insulin <ref type="bibr" target="#b29">[29]</ref>. IL-1β may suppress IRS-1 expression ERK-dependently during transcription and ERK-independently during post-transcription, which may damage insulin signaling <ref type="bibr" target="#b13">[14]</ref>. Among cytokines, IL-1β, IL-6 and TNF-α were measured and compared between the exposed and control groups in this study. Only TNF-α levels were significantly higher in the exposed group compared to controls, and IL-1β and IL-6 levels were not significantly different, though somewhat higher in the exposed group. Multiple linear regression analysis between these cytokines and organic solvents did not show any significance; however, cytokines and metabolites of organic solvents showed a significant relationship. Further, PGA, a metabolite of styrene, affected TNF-α positively, meaning that there was an increase in TNF-α levels in the exposed group, and positively correlated with PGA. It is likely that TNF-α induced an initial immune reaction and diseases such as IR with a larger quantity than required for maintaining normal physiological function. In this study, IL-6 was not significantly high; however, others have reported that it increases IR by increasing free fatty acid levels in blood <ref type="bibr" target="#b30">[30]</ref> and partly induces IR by stimulating the degradation of body fat, interrupting glucose metabolism, and decreasing the adiponectin <ref type="bibr" target="#b31">[31]</ref>.</p><p>With respect to oxidative stress, TOS and OSI were not significantly different between groups while TAC was significantly lower in the exposed group. Multiple linear regression analysis between oxidative stress indices and ambient organic solvents or their metabolites showed significant positive association between PGA and TOS, or PGA and OSI, and showed a negative association between mHA and TAC. Like cytokines, oxidative stress indices were not associated with ambient organic solvents levels but were associated with urinary metabolites. Absorbed dose seems to have stronger effect than ambient exposure level of organic solvents on the induction of physiological changes.</p><p>Most absorbed hazardous chemicals including MAHs are excreted from the body by the metabolic action of xenobioticsmetabolizing enzymes. During this process, highly active and reactive metabolic intermediates and ROS are generated, and may induce in-vivo toxicity through covalent bonding with body macromolecules <ref type="bibr" target="#b32">[32]</ref>. Such ROS toxicity in humans has been known to affect cell signaling as well as the endocrine and immune systems <ref type="bibr" target="#b33">[33]</ref>. Karagözler et al. <ref type="bibr" target="#b34">[34]</ref> reported that TNF-α was significantly increased in house painters, and the activities of superoxide dismutase and glutathione peroxidase, which are antioxidant enzymes, were significantly lower, and malondialdehyde, a measure of lipid peroxidation, was found to be significantly elevated. Styrene oxide, a metabolic intermediate of styrene, was found to decrease reduced glutathione lev- <ref type="figure">Fig. 1</ref>. Scatter-plot graph between workplace working duration and fasting glucose. Adjustment to age, smoking, drinking habit, waist and hip circumference, weight and regular exercise (r = 0.242, p = 0.014).</p><p>www.e-shaw.org els, and ROS increases were observed in clara cells incubated with styrene and its metabolites <ref type="bibr" target="#b35">[35]</ref>. In addition, styrene was reported to induce an inflammatory response by expressing glutathione S-transferase, an oxidative stress index, and expressing monocyte chemoattractant protein-1 (MCP-1), a chemotactic cytokine, through NF-κB activation <ref type="bibr" target="#b9">[10]</ref>.</p><p>NF-κB is a redox-sensitive transcription factor which reacts to cytokines, hormones, and metabolites, and plays a central role in diverse responses associated with protection via rapid gene expression induction. TNF-α, IL-1β, mitogen, oxidative stress, and inflammatory cytokines are related to its activity <ref type="bibr" target="#b36">[36]</ref>. While oxidative stress inducers including ROS have been known to result in insulin resistance by activating kinases such as JNK and IKKβ <ref type="bibr" target="#b37">[37]</ref>, hyperglycemia is known to result in oxidative stress through glucose auto-oxidation, formation of advanced glycation end products, arachidonic acid metabolism abnormality, and activation of protein kinase C <ref type="bibr" target="#b38">[38]</ref>, indicating that increases in blood glucose or oxidative stress by any reason affects reciprocally, possibly leading to a vicious circle.</p><p>In this study, multiple logistic regression analysis (with fasting glucose and HOMA-IR levels as the dependent vari-ables and MAHs exposure, cytokines, and oxidative stress as the independent variables) showed a relationship between MAHs exposure and fasting glucose. From the results above, we can confirm that MAHs exposure increases fasting glucose and IR. This high level of IR in the exposed group is thought to be due to the effect of oxidative stress and changes in physiological levels of cytokines that are generated by unchanged organic solvents and the active metabolic intermediate produced during glucose metabolism and degradation <ref type="figure" target="#fig_1">(Fig. 2)</ref>.</p><p>In conclusion, the results of the current study demonstrated that exposure to organic solvents may induce IR, though the study population were exposed to organic solvents at as low as 10% of exposure limit. Considering the recent increase of cerebro and cardiovascular diseases at workplaces and the high association between IR and cardiovascular diseases, this relationship between IR and exposure to chemical indicates that this study can be useful as basic data for the health management of workers exposed to chemicals.</p><p>Despite its relevant findings, this study has several limitations. First, the number of subjects for both the test and control group was insufficient to make clear conclusions. Second, the www.e-shaw.org subjects were exposed to MAHs at low levels, and physiological levels of cytokines and levels of oxidative stress could not be compared according to different exposure levels. Third, active metabolic intermediates, transcription factors such as NF-κB, and kinases that affect cytokines and oxidative stress were not measured but interpreted by citing the results from other researchers. Therefore, studies investigating clear mechanisms obtained via evaluating the levels of metabolic intermediates and transcription factors are needed in future research.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Exposure</head><label></label><figDesc>Coefficient of Mixture (&lt;1) 0.07 (0.01-0.80) Threshold limit value -time weighted average: Styrene: 20 ppm, Toluene: 50 ppm, Xylene: 100 ppm. Biological exposure index: Mandelic acid: 0.8 g/g creatinine, Phenylglyoxylic acid: 0.24 g/g creatinine, Hippuric acid: 2.5 g/g creatinine, Methylhippuric acid: 1.5 g/g creatinine. MAHs: monocyclic aromatic hydrocarbons.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc>Possible mechanism of insulin resistance by MAHs. MAHs: monocyclic aromatic hydrocarbons, ROSs: reactive oxygen species.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>General and job characteristics of study subjects</figDesc><table><row><cell>Variables</cell><cell>Control (n = 110) Mean ± SD</cell><cell>Exposed (n = 110) Mean ± SD</cell><cell>p-value</cell></row><row><cell>Age (years)</cell><cell>38.6 ± 8.5</cell><cell>38.9 ± 8.3</cell><cell>NS</cell></row><row><cell>TV viewing (hours/day)</cell><cell>1.4 ± 1.0</cell><cell>1.7 ± 0.9</cell><cell>0.016</cell></row><row><cell>Sleeping (hours/day)</cell><cell>6.5 ± 1.0</cell><cell>6.6 ± 0.8</cell><cell>NS</cell></row><row><cell>Smokers, n (%)</cell><cell>50 (45.5)</cell><cell>66 (60.0)</cell><cell>NS</cell></row><row><cell>Number of cigarettes/day</cell><cell>8.9 ± 8.6</cell><cell>10.6 ± 8.1</cell><cell>NS</cell></row><row><cell>Alcohol drinking, n (%)</cell><cell>93 (84.5)</cell><cell>92 (83.6)</cell><cell>NS</cell></row><row><cell>Alcohol consumption/week (g)</cell><cell>75.3 ± 60.2</cell><cell>83.5 ± 52.9</cell><cell>NS</cell></row><row><cell>Regular exercise, n (%)</cell><cell>64 (58)</cell><cell>51 (56)</cell><cell>NS</cell></row><row><cell>Eating habit</cell><cell>20.59 ± 2.91</cell><cell>20.78 ± 2.77</cell><cell>NS</cell></row><row><cell>Workplace working duration (months)</cell><cell>104.8 ± 87.1</cell><cell>124.9 ± 91.5</cell><cell>NS</cell></row><row><cell>Department working duration (months)</cell><cell>44.2 ± 56.9</cell><cell>114.8 ± 90.6</cell><cell>0.000</cell></row><row><cell>Working hours/day</cell><cell>9.9 ± 1.6</cell><cell>9.1 ± 1.4</cell><cell>0.001</cell></row><row><cell>Waist circumference (cm)</cell><cell>83.04 ± 7.65</cell><cell>84.35 ± 8.06</cell><cell>NS</cell></row><row><cell>Hip circumference (cm)</cell><cell>95.67 ± 5.03</cell><cell>95.14 ± 5.46</cell><cell>NS</cell></row><row><cell>Waist circumference/hip circumference ratio</cell><cell>0.86 ± 0.08</cell><cell>0.87 ± 0.07</cell><cell>NS</cell></row><row><cell>Boby mass index (kg/m 2 )</cell><cell>23.32 ± 2.63</cell><cell>23.94 ± 2.75</cell><cell>NS</cell></row><row><cell>Systolic blood pressure (mmHg)</cell><cell>127.07 ± 12.60</cell><cell>129.76 ± 15.65</cell><cell>NS</cell></row><row><cell>Diastolic blood pressure (mmHg)</cell><cell>75.78 ± 8.69</cell><cell>76.17 ± 10.37</cell><cell>NS</cell></row><row><cell>Weight (kg)</cell><cell>69.24 ± 8.91</cell><cell>70.39 ± 9.83</cell><cell>NS</cell></row><row><cell>Subcutaneous fat thickness (cm)</cell><cell>1.53 ± 0.50</cell><cell>1.61 ± 0.62</cell><cell>NS</cell></row><row><cell>Visceral fat thickness (cm)</cell><cell>4.33 ± 1.35</cell><cell>4.25 ± 1.35</cell><cell>NS</cell></row><row><cell>Body fat percentage (%)</cell><cell>20.04 ± 5.25</cell><cell>20.94 ± 5.43</cell><cell>NS</cell></row></table><note>SD: standard deviation, NS: non significant.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc>Concentration of ambient MAHs and their urinary metabolites in 110 exposed workers</figDesc><table><row><cell>MAHs</cell><cell>Mean (range)</cell></row><row><cell>Styrene</cell><cell></cell></row><row><cell>Ambient (ppm)</cell><cell>0.10 (0.00-5.90)</cell></row><row><cell>Metabolites (g/g Cr)</cell><cell></cell></row><row><cell>Mandelic acid</cell><cell>0.02 (0.00-0.14)</cell></row><row><cell>Phenylglyoxylic acid</cell><cell>0.02 (0.01-0.04)</cell></row><row><cell>Toluene</cell><cell></cell></row><row><cell>Ambient (ppm)</cell><cell>0.14 (0.00-2.02)</cell></row><row><cell>Metabolites (g/g Cr)</cell><cell></cell></row><row><cell>Hippuric acid</cell><cell>0.30 (0.01-1.34)</cell></row><row><cell>Xylene</cell><cell></cell></row><row><cell>Ambient (ppm)</cell><cell>8.83 (0.00-32.65)</cell></row><row><cell>Metabolites (g/g Cr)</cell><cell></cell></row><row><cell>Methylhippuric acid</cell><cell>0.09 (0.00-0.48)</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc>Comparison of serum clinical parameters between control and exposed workers</figDesc><table><row><cell>Variables</cell><cell>Control (n = 110) Mean ± SD</cell><cell>Exposed (n = 110) Mean ± SD</cell><cell>p-value</cell></row><row><cell>Total cholesterol (mg/dL)</cell><cell>184.19 ± 31.27</cell><cell>194.29 ± 33.80</cell><cell>0.024</cell></row><row><cell>HDL-cholesterol (mg/dL)</cell><cell>48.10 ± 12.56</cell><cell>50.28 ± 10.35</cell><cell>NS</cell></row><row><cell>LDL-cholesterol (mg/dL)</cell><cell>112.47 ± 29.13</cell><cell>112.22 ± 31.99</cell><cell>NS</cell></row><row><cell>Triglyceride (mg/dL)</cell><cell>164.68 ± 113.86</cell><cell>189.88 ± 159.36</cell><cell>NS</cell></row><row><cell>Fasting glucose (mg/dL)</cell><cell>89.03 ± 11.81</cell><cell>93.17 ± 15.36</cell><cell>0.027</cell></row><row><cell>Fasting insulin (μIU/mL)</cell><cell>6.83 ± 5.49</cell><cell>8.81 ± 6.89</cell><cell>0.019</cell></row><row><cell>HOMA-IR</cell><cell>1.55 ± 1.36</cell><cell>2.12 ± 1.89</cell><cell>0.010</cell></row><row><cell>IL-1β (pg/mL)</cell><cell>0.254 ± 0.234</cell><cell>0.333 ± 0.441</cell><cell>NS</cell></row><row><cell>IL-6 (pg/mL)</cell><cell>1.689 ± 1.006</cell><cell>1.916 ± 1.908</cell><cell>NS</cell></row><row><cell>TNF-α (pg/mL)</cell><cell>2.380 ± 1.635</cell><cell>4.785 ± 1.975</cell><cell>0.001</cell></row><row><cell>TOS (μmol H 2 O 2 equivalent/L)</cell><cell>138.1 ± 63.4</cell><cell>135.8 ± 71.7</cell><cell>NS</cell></row><row><cell>TAC (μmol H 2 O 2 equivalent/L)</cell><cell>316.1 ± 34.0</cell><cell>297.7 ± 45.6</cell><cell>0.001</cell></row><row><cell>OSI</cell><cell>0.444 ± 0.2</cell><cell>0.482 ± 0.3</cell><cell>NS</cell></row></table><note>SD: standard deviation, NS: Non-significant, HOMA-IR: homeostasis model assessment of insulin resistance, IL-1β: interleukin-1 beta, IL-6: inter- leukin-6, TNF-α: tumor necrosis factor-alpha, TOS: total oxidative status, TAC: total anti-oxidative capacity, OSI: oxidative stress index.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 .</head><label>4</label><figDesc>Results of a multiple linear regression model for the association among MAHs metabolites, cytokines, and oxidative stress indices</figDesc><table><row><cell>Dependent variable</cell><cell></cell><cell cols="2">TNF-α</cell><cell></cell><cell></cell><cell>IL-6</cell><cell></cell><cell></cell><cell></cell><cell cols="2">IL-1β</cell><cell></cell></row><row><cell>Independent variables</cell><cell>B</cell><cell>SE</cell><cell>Beta</cell><cell>t</cell><cell>B</cell><cell>SE</cell><cell>Beta</cell><cell>t</cell><cell>B</cell><cell>SE</cell><cell>Beta</cell><cell>t</cell></row><row><cell>(Constant)</cell><cell>2.390</cell><cell>0.888</cell><cell></cell><cell>2.691*</cell><cell>1.639</cell><cell>0.893</cell><cell></cell><cell>1.836</cell><cell cols="2">0.175 0.078</cell><cell></cell><cell>2.252</cell></row><row><cell>MA</cell><cell>69.708</cell><cell>34.188</cell><cell cols="2">0.382 2.039</cell><cell>11.181</cell><cell>15.789</cell><cell>0.142</cell><cell>0.708</cell><cell cols="4">0.389 1.358 0.058 0.286</cell></row><row><cell>PGA</cell><cell>119.897</cell><cell>43.492</cell><cell cols="2">0.560 2.757*</cell><cell>-14.141</cell><cell cols="2">35.914 -0.085</cell><cell>-0.394</cell><cell cols="4">-0.138 2.935 -0.010 -0.047</cell></row><row><cell>HA</cell><cell>-1.846</cell><cell cols="3">1.231 -0.256 -1.499</cell><cell>-0.520</cell><cell cols="2">1.610 -0.067</cell><cell>-0.323</cell><cell cols="4">0.226 0.151 0.323 1.499</cell></row><row><cell>mHA</cell><cell>-4.217</cell><cell cols="3">2.336 -0.324 -1.805</cell><cell>3.136</cell><cell>3.421</cell><cell>0.206</cell><cell>-0.917</cell><cell cols="4">-0.053 0.311 -0.040 -0.170</cell></row><row><cell>R 2</cell><cell>0.614</cell><cell></cell><cell></cell><cell></cell><cell>0.048</cell><cell></cell><cell></cell><cell></cell><cell>0.102</cell><cell></cell><cell></cell><cell></cell></row><row><cell>F</cell><cell>5.559  †</cell><cell></cell><cell></cell><cell></cell><cell>0.305</cell><cell></cell><cell></cell><cell></cell><cell>0.657</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Dependent variable</cell><cell></cell><cell cols="2">TOS</cell><cell></cell><cell></cell><cell>TAC</cell><cell></cell><cell></cell><cell></cell><cell cols="2">OSI</cell><cell></cell></row><row><cell>Independent variables</cell><cell>B</cell><cell>SE</cell><cell>Beta</cell><cell>t</cell><cell>B</cell><cell>SE</cell><cell>Beta</cell><cell>t</cell><cell>B</cell><cell>SE</cell><cell>Beta</cell><cell>t</cell></row><row><cell>(Constant)</cell><cell>76.432</cell><cell cols="2">32.719</cell><cell cols="2">2.336* 330.428</cell><cell>19.453</cell><cell></cell><cell>16.986  ‡</cell><cell cols="2">0.186 0.123</cell><cell></cell><cell>1.509</cell></row><row><cell>MA</cell><cell>-99.662</cell><cell cols="3">596.064 -0.026 -0.167</cell><cell cols="3">-111.632 354.395 -0.052</cell><cell>-0.315</cell><cell cols="4">-0.223 2.244 -0.015 -0.099</cell></row><row><cell>PGA</cell><cell cols="5">4,709.418 1,327.647 0.598 3.547  † -584.676</cell><cell cols="2">79.364 -0.131</cell><cell>-0.741</cell><cell cols="4">17.304 4.998 0.557 3.462  †</cell></row><row><cell>HA</cell><cell>28.995</cell><cell cols="3">61.090 0.078 0.475</cell><cell>31.496</cell><cell>36.322</cell><cell>0.149</cell><cell>0.867</cell><cell cols="4">0.106 0.230 0.072 0.461</cell></row><row><cell>mHA</cell><cell>-1.654</cell><cell cols="3">128.270 -0.002 -0.013</cell><cell>-210.794</cell><cell cols="2">76.264 -0.514</cell><cell>-2.764*</cell><cell cols="4">0.477 0.483 0.167 0.989</cell></row><row><cell>R 2</cell><cell>0.369</cell><cell></cell><cell></cell><cell></cell><cell>0.303</cell><cell></cell><cell></cell><cell></cell><cell>0.426</cell><cell></cell><cell></cell><cell></cell></row><row><cell>F</cell><cell>3.803*</cell><cell></cell><cell></cell><cell></cell><cell>2.830*</cell><cell></cell><cell></cell><cell></cell><cell>4.814  †</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="13">MA: mandelic acid, PGA: phenylglyoxylic acid, HA: hippuric acid, mHA: methylhippuric acid, TNF-α: tumor necrosis factor-alpha, IL-6: interleu-</cell></row><row><cell cols="10">kin-6, IL-1β: interleukin-1 beta, TOS: total oxidative status, TAC: total anti-oxidative capacity, OSI: oxidative stress index.</cell><cell></cell><cell></cell><cell></cell></row><row><cell>*p &lt; 0.05.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>† p &lt; 0.01.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>‡ p &lt; 0.001.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">Table 5. Multiple logistic regression analysis for fasting glu-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">cose and HOMA-IR</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Variables</cell><cell>β</cell><cell>SE</cell><cell cols="2">OR (95% CI)</cell><cell>p-value</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">Fasting glucose 1.374 0.664 3.951 (1.074-14.530) 0.039</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>HOMA-IR</cell><cell cols="4">0.538 0.360 1.713 (0.846-3.469)</cell><cell>0.135</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">Independent variable: exposure levels of monocyclic aromatic hy-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>drocarbons.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">Adjustment to age, smoking, drinking habit, waist and hip circum-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">ference, weight and regular exercise.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note>SE: standard error, OR: odds ratio, CI: confidence interval, HOMA-IR: homeostasis model assessment of insulin resistance.</note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.e-shaw.org</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>This study was supported by the intramural research fund of the Occupational Safety and Health Research Institute (OSHRI).</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interest</head><p>No potential conflict of interest relevant to this article was reported.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The diagnosis and management of solvent-related disorders</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean</forename><forename type="middle">Q</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><forename type="middle">M</forename><surname>Levin</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1097-0274(200001)37:1&lt;44::aid-ajim5&gt;3.0.co;2-k</idno>
		<idno type="PMID">10573596</idno>
		<idno type="ark">ark:/67375/WNG-TS17J41W-W</idno>
		<idno type="istexId">D6B2310E70C47F57AB1BF23CF20DA659DC9D13EC</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Industrial Medicine</title>
		<title level="j" type="abbrev">Am J Ind Med</title>
		<idno type="ISSN">0271-3586</idno>
		<idno type="ISSNe">1097-0274</idno>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="44" to="61" />
			<date type="published" when="2000-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Hepatotoxic effects of workplace exposure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><surname>Warnes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1201/b13467-123</idno>
	</analytic>
	<monogr>
		<title level="m">Hunter&apos;s Diseases of Occupations, Tenth Edition</title>
		<meeting><address><addrLine>London (UK</addrLine></address></meeting>
		<imprint>
			<publisher>CRC Press</publisher>
			<date type="published" when="2010-10-29" />
			<biblScope unit="page" from="1171" to="1195" />
		</imprint>
	</monogr>
	<note>Hunter&apos;s diseases of occupations. 9th ed.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Industrial solvents and liver toxicity: Risk assessment, risk factors and mechanisms</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nachman</forename><surname>Brautbar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.1078/1438-4639-00175</idno>
		<idno type="PMID">12455270</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Hygiene and Environmental Health</title>
		<title level="j" type="abbrev">International Journal of Hygiene and Environmental Health</title>
		<idno type="ISSN">1438-4639</idno>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="479" to="491" />
			<date type="published" when="2002-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Benzene-induced acute myeloid leukemia: A clinician&apos;s perspective</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ethan</forename><forename type="middle">A</forename><surname>Natelson</surname></persName>
		</author>
		<idno type="DOI">10.1002/ajh.20934</idno>
		<idno type="PMID">17506065</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Hematology</title>
		<title level="j" type="abbrev">Am. J. Hematol.</title>
		<idno type="ISSN">0361-8609</idno>
		<idno type="ISSNe">1096-8652</idno>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="826" to="830" />
			<date type="published" when="2007-09" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Solvents and neurotoxicity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberta</forename><forename type="middle">F</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">P</forename><surname>Proctor</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(96)07218-2</idno>
		<idno type="PMID">9130958</idno>
		<idno type="PII">S0140-6736(96)07218-2</idno>
		<idno type="ark">ark:/67375/6H6-CVC38CR8-L</idno>
		<idno type="istexId">D85508A7D17FB5B54C3B14769C046FDF2822A387</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="issue">9060</biblScope>
			<biblScope unit="page" from="1239" to="1243" />
			<date type="published" when="1997-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">An experimental model for the determination of immunomodulating effects by volatile compounds</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gunnar</forename><surname>Wichmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jana</forename><surname>Mühlenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gundula</forename><surname>Fischäder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christian</forename><surname>Kulla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martina</forename><surname>Rehwagen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olf</forename><surname>Herbarth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irina</forename><surname>Lehmann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tiv.2005.03.012</idno>
		<idno type="PMID">15885978</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology in Vitro</title>
		<title level="j" type="abbrev">Toxicology in Vitro</title>
		<idno type="ISSN">0887-2333</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="685" to="693" />
			<date type="published" when="2005-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">TH1-directed modulation of in vitro cytokine production in human peripheral blood mononuclear cells by styrene-7.8-oxide</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Georg</forename><forename type="middle">H</forename><surname>Merker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerhard</forename><surname>Metzner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ferdinand</forename><surname>Raabe</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.toxlet.2005.06.014</idno>
		<idno type="PMID">16111840</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology Letters</title>
		<title level="j" type="abbrev">Toxicology Letters</title>
		<idno type="ISSN">0378-4274</idno>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="105" to="111" />
			<date type="published" when="2006-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Results of common laboratory tests in solvent-exposed workers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ari</forename><surname>Kaukiainen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tapio</forename><surname>Vehmas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kaarina</forename><surname>Rantala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Markku</forename><surname>Nurminen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rami</forename><surname>Martikainen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helena</forename><surname>Taskinen</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00420-003-0476-z</idno>
		<idno type="PMID">14600835</idno>
		<idno type="ark">ark:/67375/VQC-G9XN3VSW-9</idno>
		<idno type="istexId">E53195D771E28915BDE9924DA5D4642511C4F37E</idno>
	</analytic>
	<monogr>
		<title level="j">International Archives of Occupational and Environmental Health</title>
		<title level="j" type="abbrev">International Archives of Occupational and Environmental Health</title>
		<idno type="ISSN">0340-0131</idno>
		<idno type="ISSNe">1432-1246</idno>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="39" to="46" />
			<date type="published" when="2004-01-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Community level exposure to chemicals and oxidative stress in adult population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yun-Chul</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eun-Young</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min-Seon</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeong</forename><forename type="middle">Ah</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Se-Young</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ho</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kwan-Hee</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jong-Han</forename><surname>Leem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eun-Hee</forename><surname>Ha</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.toxlet.2008.11.001</idno>
		<idno type="PMID">19049859</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology Letters</title>
		<title level="j" type="abbrev">Toxicology Letters</title>
		<idno type="ISSN">0378-4274</idno>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="139" to="144" />
			<date type="published" when="2009-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Styrene induces an inflammatory response in human lung epithelial cells via oxidative stress and NF-κB activation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carmen</forename><surname>Röder-Stolinski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gundula</forename><surname>Fischäder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gertie</forename><forename type="middle">Janneke</forename><surname>Oostingh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ralph</forename><surname>Feltens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Franziska</forename><surname>Kohse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Von Bergen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nora</forename><surname>Mörbt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Klaus</forename><surname>Eder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Albert</forename><surname>Duschl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irina</forename><surname>Lehmann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.taap.2008.04.010</idno>
		<idno type="PMID">18554678</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology and Applied Pharmacology</title>
		<title level="j" type="abbrev">Toxicology and Applied Pharmacology</title>
		<idno type="ISSN">0041-008X</idno>
		<imprint>
			<biblScope unit="volume">231</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="241" to="247" />
			<date type="published" when="2008-09-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Oxidative Stress in Chemical Toxicity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kappus</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-3-642-76874-3_2</idno>
	</analytic>
	<monogr>
		<title level="m">Free Radicals and the Liver</title>
		<imprint>
			<publisher>Springer Berlin Heidelberg</publisher>
			<date type="published" when="1992" />
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="13" to="20" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Antioxidants in of shoe-makers exposed to organic solvents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">S</forename><surname>Hussein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Abdalla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Hussein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">G</forename><surname>Shousha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">H</forename><surname>Mohame</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Appl Sci Res</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1107" to="1124" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victoria</forename><surname>Rotter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ivan</forename><surname>Nagaev</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ulf</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m301977200</idno>
		<idno type="PMID">12952969</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/278/46/45777.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="issue">46</biblScope>
			<biblScope unit="page" from="45777" to="45784" />
			<date type="published" when="2003-09-02" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Interleukin-1β-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><surname>Jager</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thierry</forename><surname>Grémeaux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mireille</forename><surname>Cormont</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yannick</forename><surname>Le Marchand-Brustel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean-François</forename><surname>Tanti</surname></persName>
		</author>
		<idno type="DOI">10.1210/en.2006-0692</idno>
		<idno type="PMID">17038556</idno>
		<idno type="PMCID">PMC1971114</idno>
		<ptr type="open-access" target="https://academic.oup.com/endo/article-pdf/148/1/241/9032317/endo0241.pdf" />
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<title level="j" type="abbrev">Endocrinology</title>
		<idno type="ISSN">0013-7227</idno>
		<idno type="ISSNe">1945-7170</idno>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="241" to="251" />
			<date type="published" when="2007-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Salicylate inhibition of IKK (IκB kinase) reverses insulin resistance in Zucker (fa/fa) rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Konstantopoulos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">E</forename><surname>Shoelson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">292</biblScope>
			<date type="published" when="2000" />
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">A central role for JNK in obesity and insulin resistance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jiro</forename><surname>Hirosumi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gürol</forename><surname>Tuncman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lufen</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cem</forename><forename type="middle">Z</forename><surname>Görgün</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Teoman</forename><surname>Uysal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhisa</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Karin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gökhan</forename><forename type="middle">S</forename><surname>Hotamisligil</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature01137</idno>
		<idno type="PMID">12447443</idno>
		<idno type="ark">ark:/67375/GT4-R2NL873P-Z</idno>
		<idno type="istexId">EEAC69BB31F40E54485A299D957D4EC95B3D86AB</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<imprint>
			<biblScope unit="volume">420</biblScope>
			<biblScope unit="issue">6913</biblScope>
			<biblScope unit="page" from="333" to="336" />
			<date type="published" when="2002-11-21" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">): National Institute of Occupational Safety and Health</title>
	</analytic>
	<monogr>
		<title level="m">NIOSH manual of analytical methods</title>
		<editor>Eller PM, Cassinelli ME</editor>
		<meeting><address><addrLine>Cincinnati (OH</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1994" />
		</imprint>
		<respStmt>
			<orgName>National Institute of Occupational Safety and Health</orgName>
		</respStmt>
	</monogr>
	<note>Method 1501</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">A new derivatization procedure for the analysis of hippuric acid and m-methyl-hippuric acid by gas chromatography</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>De Carvalho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">L</forename><surname>Lanchote</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">S</forename><surname>Bonato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H C</forename><surname>Queiroz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">C</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A C</forename><surname>Dreossi</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf00406195</idno>
		<idno type="PMID">1856021</idno>
		<idno type="ark">ark:/67375/1BB-3FDDK2CT-H</idno>
		<idno type="istexId">BB6C14F2AD2504442528393EBA20345B9EEEC2D5</idno>
	</analytic>
	<monogr>
		<title level="j">International Archives of Occupational and Environmental Health</title>
		<title level="j" type="abbrev">Int. Arch Occup Environ Heath</title>
		<idno type="ISSN">0340-0131</idno>
		<idno type="ISSNe">1432-1246</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="37" />
			<date type="published" when="1991-05" />
			<publisher>Springer Nature America, Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Simultaneous determination of urinary creatinine and metabolites of toluene, xylene, styrene, ethylbenzene and phenol by automated high performance liquid chromatography</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masana</forename><surname>Ogata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toyohiro</forename><surname>Taguchi</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf00381617</idno>
		<idno type="PMID">3198279</idno>
		<idno type="ark">ark:/67375/1BB-SB44H2KD-V</idno>
		<idno type="istexId">9DB9E8FED3690BAE40CDAC7C28504B207E505BB1</idno>
	</analytic>
	<monogr>
		<title level="j">International Archives of Occupational and Environmental Health</title>
		<title level="j" type="abbrev">Int. Arch Occup Environ Heath</title>
		<idno type="ISSN">0340-0131</idno>
		<idno type="ISSNe">1432-1246</idno>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="131" to="140" />
			<date type="published" when="1988-10" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Report of the expert committee on the diagnosis and classification of diabetes mellitus</title>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="5" to="20" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
	<note>Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Suppl</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Television Viewing and Hypertension in Obese Children</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Perrie</forename><forename type="middle">E</forename><surname>Pardee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gregory</forename><forename type="middle">J</forename><surname>Norman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">H</forename><surname>Lustig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Preud’homme</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">B</forename><surname>Schwimmer</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2007.07.036</idno>
		<idno type="PMID">18022058</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Preventive Medicine</title>
		<title level="j" type="abbrev">American Journal of Preventive Medicine</title>
		<idno type="ISSN">0749-3797</idno>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="439" to="443" />
			<date type="published" when="2007-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Longitudinal Associations Between Television Viewing and Body Mass Index Among White and Black Girls</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vani</forename><forename type="middle">R</forename><surname>Henderson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jadohealth.2007.04.018</idno>
		<idno type="PMID">18023782</idno>
		<idno type="PMCID">PMC2128759</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2128759?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Journal of Adolescent Health</title>
		<title level="j" type="abbrev">Journal of Adolescent Health</title>
		<idno type="ISSN">1054-139X</idno>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="544" to="550" />
			<date type="published" when="2007-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Occupational Sitting Time and Overweight and Obesity in Australian Workers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">Kerry</forename><surname>Mummery</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Grant</forename><forename type="middle">M</forename><surname>Schofield</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rebekah</forename><surname>Steele</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elizabeth</forename><forename type="middle">G</forename><surname>Eakin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wendy</forename><forename type="middle">J</forename><surname>Brown</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2005.04.003</idno>
		<idno type="PMID">16005804</idno>
		<ptr target="Brownwww.e-shaw.org" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Preventive Medicine</title>
		<title level="j" type="abbrev">American Journal of Preventive Medicine</title>
		<idno type="ISSN">0749-3797</idno>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="91" to="97" />
			<date type="published" when="2005-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Occupational sitting time and overweight and obesity in Australian workers</title>
	</analytic>
	<monogr>
		<title level="j">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="91" to="98" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
	<note>WJ</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Sedentary lifestyle: physical activity duration versus percentage of energy expenditure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Cabrera De León</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rodríguez-Pérez</forename><surname>Mdel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Rodríguez-Benjumeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Anía-Lafuente</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Brito-Díaz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Muros</forename><surname>De Fuentes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Almeida-González</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Batista-Medina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aguirre-Jaime</forename></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Esp Cardiol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="244" to="50" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Impaired Glucose Uptake and Intact Gluconeogenesis in Perfused Rat Liver After Carbon Tetrachloride Injury</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Mokuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Ubukata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Sakamoto</surname></persName>
		</author>
		<idno type="DOI">10.1006/bmme.1995.1006</idno>
		<idno type="PMID">7551815</idno>
		<idno type="PII">S1077-3150(85)71006-X</idno>
		<idno type="ark">ark:/67375/6H6-6SGVG2B1-W</idno>
		<idno type="istexId">6DA391294FC7D344265BB385D4ED5119CD4B489C</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Molecular Medicine</title>
		<title level="j" type="abbrev">Biochemical and Molecular Medicine</title>
		<idno type="ISSN">1077-3150</idno>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="38" to="42" />
			<date type="published" when="1995-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title level="m" type="main">Incheon (Korea): Occupational Safety and Health Research Institute</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">G</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">L</forename><surname>Won</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Heo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">G</forename><surname>Kim</surname></persName>
		</author>
		<idno>No.: OSHRI 2008-25- 36. 49 p. Korean</idno>
		<imprint>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
	<note type="report_type">Report</note>
	<note>Exposure of hazardous chemicals and metabolic syndrome (I)</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">S</forename><surname>Hotamisligil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">S</forename><surname>Shargill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">M</forename><surname>Spiegelman</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.7678183</idno>
		<idno type="PMID">7678183</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<title level="j" type="abbrev">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">259</biblScope>
			<biblScope unit="issue">5091</biblScope>
			<biblScope unit="page" from="87" to="91" />
			<date type="published" when="1993-01-01" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lawrence</forename><surname>Shapiro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philipp</forename><forename type="middle">E</forename><surname>Scherer</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0960-9822(98)70133-2</idno>
		<idno type="PMID">9512423</idno>
		<idno type="PII">S0960-9822(98)70133-2</idno>
		<idno type="ark">ark:/67375/6H6-9P93F68B-0</idno>
		<idno type="istexId">7848A73852B16A899C883CFC2BFE204B4B98CD12</idno>
	</analytic>
	<monogr>
		<title level="j">Current Biology</title>
		<title level="j" type="abbrev">Current Biology</title>
		<idno type="ISSN">0960-9822</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="335" to="340" />
			<date type="published" when="1998-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hong</forename><surname>Ruan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harvey</forename><forename type="middle">F</forename><surname>Lodish</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1359-6101(03)00052-2</idno>
		<idno type="PMID">12948526</idno>
	</analytic>
	<monogr>
		<title level="j">Cytokine &amp; Growth Factor Reviews</title>
		<title level="j" type="abbrev">Cytokine &amp; Growth Factor Reviews</title>
		<idno type="ISSN">1359-6101</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="447" to="455" />
			<date type="published" when="2003-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Boden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">I</forename><surname>Shulman</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2362.32.s3.3.x</idno>
		<idno type="PMID">12028371</idno>
		<idno type="ark">ark:/67375/WNG-MR50NBH4-P</idno>
		<idno type="istexId">00800A075AB64883286D297BC57637CCB6738AAE</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">Eur J Clin Invest</title>
		<idno type="ISSN">0014-2972</idno>
		<idno type="ISSNe">1365-2362</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">s3</biblScope>
			<biblScope unit="page" from="14" to="23" />
			<date type="published" when="2002-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Insulin Resistance in Type 2 Diabetes - Role of the Adipokines</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Arner</surname></persName>
		</author>
		<idno type="DOI">10.2174/1566524053766022</idno>
		<idno type="PMID">15892652</idno>
	</analytic>
	<monogr>
		<title level="j">Current Molecular Medicine</title>
		<title level="j" type="abbrev">CMM</title>
		<idno type="ISSN">1566-5240</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="333" to="339" />
			<date type="published" when="2005-05-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Mechanisms of Acetaminophen Toxicity: Immunochemical Detection of Drug-Protein Adducts</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jack</forename><forename type="middle">A</forename><surname>Hinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Neil</forename><forename type="middle">R</forename><surname>Pumford</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dean</forename><forename type="middle">W</forename><surname>Roberts</surname></persName>
		</author>
		<idno type="DOI">10.3109/03602539509029816</idno>
		<idno type="PMID">7641586</idno>
	</analytic>
	<monogr>
		<title level="j">Drug Metabolism Reviews</title>
		<title level="j" type="abbrev">Drug Metabolism Reviews</title>
		<idno type="ISSN">0360-2532</idno>
		<idno type="ISSNe">1097-9883</idno>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="73" to="92" />
			<date type="published" when="1995-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hüsamettin</forename><surname>Erdamar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hüseyin</forename><surname>Demirci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Halil</forename><surname>Yaman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">Kemal</forename><surname>Erbil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tolga</forename><surname>Yakar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Banu</forename><surname>Sancak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sehri</forename><surname>Elbeg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gürsel</forename><surname>Biberoğlu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">İlhan</forename><surname>Yetkin</surname></persName>
		</author>
		<idno type="DOI">10.1515/cclm.2008.183</idno>
		<idno type="PMID">18605962</idno>
		<idno type="ark">ark:/67375/QT4-VSK4LM44-G</idno>
		<idno type="istexId">A945497650243C1C184DD184FBB3CDF155D4625E</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Chemistry and Laboratory Medicine</title>
		<idno type="ISSN">1434-6621</idno>
		<idno type="ISSNe">1437-4331</idno>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1004" to="1014" />
			<date type="published" when="2008-01-01" />
			<publisher>Walter de Gruyter GmbH</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">EFFECTS OF LONG-TERM SOLVENT EXPOSURE ON BLOOD CYTOKINE LEVELS AND ANTIOXIDANT ENZYME ACTIVITIES IN HOUSE PAINTERS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">Alev</forename><surname>Karagözler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nihayet</forename><surname>Mehmet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kadir</forename><surname>Batçioglu</surname></persName>
		</author>
		<idno type="DOI">10.1080/152873902760125723</idno>
		<idno type="PMID">12167207</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Toxicology and Environmental Health, Part A</title>
		<title level="j" type="abbrev">Journal of Toxicology and Environmental Health, Part A</title>
		<idno type="ISSN">1528-7394</idno>
		<idno type="ISSNe">1087-2620</idno>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="1237" to="1246" />
			<date type="published" when="2002-08-30" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Effects of styrene and styrene oxide on glutathione-related antioxidant enzymes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gary</forename><forename type="middle">P</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Meredith</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nancy</forename><forename type="middle">A</forename><surname>Mantick</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tox.2006.08.006</idno>
		<idno type="PMID">16971035</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology</title>
		<title level="j" type="abbrev">Toxicology</title>
		<idno type="ISSN">0300-483X</idno>
		<imprint>
			<biblScope unit="volume">227</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="217" to="226" />
			<date type="published" when="2006-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Transcription factor NF-κB as a potential biomarker for oxidative stress</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Van Den Berg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">R M M</forename><surname>Haenen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Van Den Berg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Bast</surname></persName>
		</author>
		<idno type="DOI">10.1079/bjn2001340</idno>
		<idno type="PMID">11520430</idno>
		<idno type="PII">S0007114501001866</idno>
		<idno type="ark">ark:/67375/6GQ-3LZSQM4G-2</idno>
		<idno type="istexId">CE0C55366A043745ACE7FCF425983A51E5ABDDAB</idno>
		<ptr type="open-access" target="https://www.cambridge.org/core/services/aop-cambridge-core/content/view/D164881651DDFBE4B8FEA942271E91CA/S0007114501001866a.pdf/div-class-title-transcription-factor-nf-b-as-a-potential-biomarker-for-oxidative-stress-div.pdf" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Nutrition</title>
		<title level="j" type="abbrev">BJN</title>
		<idno type="ISSN">0007-1145</idno>
		<idno type="ISSNe">1475-2662</idno>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="issue">S1</biblScope>
			<biblScope unit="page">S121</biblScope>
			<date type="published" when="2001-08" />
			<publisher>Cambridge University Press (CUP)</publisher>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Metabolic stress in insulin&apos;s target cells leads to ROS accumulation - A hypothetical common pathway causing insulin resistance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jan</forename><forename type="middle">W</forename><surname>Eriksson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.febslet.2007.06.044</idno>
		<idno type="PMID">17628546</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Letters</title>
		<idno type="ISSN">0014-5793</idno>
		<imprint>
			<biblScope unit="volume">581</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="3734" to="3742" />
			<date type="published" when="2007-06-27" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ignazio</forename><surname>Grattagliano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vincenzo</forename><forename type="middle">O</forename><surname>Palmieri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Piero</forename><surname>Portincasa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonio</forename><surname>Moschetta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giuseppe</forename><surname>Palasciano</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jnutbio.2007.06.011</idno>
		<idno type="PMID">17855068</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Nutritional Biochemistry</title>
		<title level="j" type="abbrev">The Journal of Nutritional Biochemistry</title>
		<idno type="ISSN">0955-2863</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="491" to="504" />
			<date type="published" when="2008-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
